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Background
The pharmacological manipulation of the interaction
between the immune system, fibroblasts and cancer cells
has been proven to be a key target for cancer therapy.
Based on our previously developed co-culture system,
this work aims to develop an innovative 3D cell culture
system consisting of immune cells, fibroblasts and can-
cer cells and to investigate then influence of the tumor
microenvironment on the infiltration of immune cells.
Methods
3D tumor microtissues were cultivated using a “hanging
drop” system. The human non-small cell lung cancer
(NSCLC) cell lines A549 and Calu-6 with or without the
human fibroblast cell line SV80 were incubated for 11 and
12 days to form microtissues. On day 10, peripheral blood
mononuclear cells (PBMC) were added either with or
without interleukin-2 (IL-2) for either 24 hours or 48
hours. The infiltration of PBMCs into the cancer cell and
cancer cell/fibroblast microtissues was analyzed by immu-
nohistochemistry (IHC). Quantification of the infiltrating
subpopulations were performed with flow cytometry using
surface staining on the cluster of differentiation (CD) 3,
CD8, CD14, CD28, CD45, and CD45R0+.
Results
Immunohistochemical staining revealed PBMC infiltra-
tion in cancer cell and cancer cell/fibroblast microtissues.
In the A549/SV80 microtissues, PBMCs were located
within the cancer cell compartment and hardly migrated
into the fibroblast backbone of the microtissues. In the
Calu-6/SV80 microtissues, the fibroblasts located at the
margin of the microtissue seemed to prevent PBMCs
from infiltrating into the cancer cell compartment. In
both co-cultures and tri-cultures, infiltration of lympho-
cytes (CD14-) and monocytes (CD14+) was observed,
with the proportion of lymphocytes prevailing the latter
one. Under IL-2 stimulation, the percentage of CD14-
lymphocytes and their subpopulations of CD3+CD8+ as
well as CD45R0+ cells increased while the percentage of
CD28+ cells decreased in both co- and tri-cultures.
Conclusion
Our model shows that lymphocyte and activated effector
T-cell infiltration into the cancer cell/fibroblast microtis-
sues is stimulated by the addition of IL-2. We provide
evidence that our 3D co-culture model is an effective
tool to study interactions between cancer cells, fibroblasts
and immune cells and to evaluate novel biomarkers for
immunotherapy.
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